Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-07-11

Clinical Trial Update: Iron Dextran Versus Oral Iron for Treating Iron Deficiency Anemia in Pregnant Women [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing iron dextran to oral iron for treating iron deficiency anemia in pregnant women has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ferrous sulfate (oral iron) (ferrous sulfate)
  • Iron Dextran (iron dextran)

Snippet

Sponsor: Assiut University | Conditions: Anemia | Phase 3 | Status: COMPLETED